Cargando…
ZEB1: A Critical Regulator of Cell Plasticity, DNA Damage Response, and Therapy Resistance
The predominant way in which conventional chemotherapy kills rapidly proliferating cancer cells is the induction of DNA damage. However, chemoresistance remains the main obstacle to therapy effectivity. An increasing number of studies suggest that epithelial-to-mesenchymal transition (EMT) represent...
Autores principales: | Drápela, Stanislav, Bouchal, Jan, Jolly, Mohit Kumar, Culig, Zoran, Souček, Karel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096573/ https://www.ncbi.nlm.nih.gov/pubmed/32266287 http://dx.doi.org/10.3389/fmolb.2020.00036 |
Ejemplares similares
-
Editorial: Heterogeneity and plasticity of prostate cancer
por: Culig, Zoran, et al.
Publicado: (2023) -
Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance
por: Muresan, Ximena Maria, et al.
Publicado: (2020) -
Editorial: Characterizing the Multi-Faceted Dynamics of Tumor Cell Plasticity
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2021) -
Cancer Stem Cell Plasticity – A Deadly Deal
por: Thankamony, Archana P., et al.
Publicado: (2020) -
Circulating tumor cell-derived preclinical models: current status and future perspectives
por: Kahounová, Zuzana, et al.
Publicado: (2023)